Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy

导出原文传递

翻译打印收藏纠错

作者： Hicks, Kristin C. ^[1] ; Knudson, Karin M. ^[2] ; Lee, Karin L. ^[3] ; Hamilton, Duane H. ^[4] ; Hodge, James W. ; Figg, William D. ; Ordentlich, Peter ; Jones, Frank R. ; Rabizadeh, Shahrooz ; Soon-Shiong, Patrick ; Schlom, Jeffrey ; Gameiro, Sofia R.

作者单位： ImmunityBio, Culver City, CA USA ^[1] NCI, Tumor Immunol & Biol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA ^[2] NCI, Clin Pharmacol Program, Off Clin Director, Ctr Canc Res,NIH, Bethesda, MD 20892 USA ^[3] Syndax Pharmaceut Inc, Waltham, MA USA ^[4]

发布时间 2020-10-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Clinical cancer research

2020年26卷3期

704-716页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除